3
Views
1
CrossRef citations to date
0
Altmetric
Research

Patent Update Anti-infectives: Developments in herpesviruses 1995

&
Pages 753-763 | Published online: 29 Feb 2008

References to Primary Literature

  • ROCK DL: The molecular basis of latent infections by alphaherpesviruses. Semin. Virol. (1993) 4:157–165.
  • FAWL RL, ROIZMAN 13: The molecular basis of herpes simplex virus pathogenicity. Semin. Virol. (1994) 5:261–271.
  • AHMED R, MORRISON LA, KNIPE DM: Persistence of viruses. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York (1996):219–250.
  • ROIZMAN B, SEARS AE: Herpes simplex viruses and their replication. In: The Human Herpes Viruses. Roizman B, Lopez C, Whitley RJ (Eds.), Raven Press, New York (1993):11–16.
  • WARD PL, ROIZMAN B: Herpes simplex genes: blueprint for a successful human pathogen. Trends Genetics (1994) 10:267–274.
  • CHA TA, TOM E, KEMBLE GW et al.: Human cytomega-lovirus clinical isolates carry at least 19 genes not found In laboratory strains. J. Virol. (1996) 70:78–83.
  • MESRI EA, CESARMEN E, ARVANITAKIS L et al.: Human herpes virus-8 Kaposi's sarcoma-associated herpes-virus is a new transmissible virus that infects B cells. Exp. Med. (1996) 183:2385–2390.
  • WHITE DO, FENNER FJ: Herpesviridae. In: Medical Virol-ogy. White DO, Fenner FJ (Eds.), Academic Press (1994):318–347.
  • SACKS L, ALRABIAH F: Novel herpes treatments: a re-view. Exp. Opin. Invest. Drugs (1996) 5:169–183.
  • BEUTNER KR: Valacklovir: a review of its antiviral activ-ity, pharmacokinetic properties, and clinical efficacy. Antiviral Res. (1995) 28:281–290.
  • CIRELLI R, HERNE K, MCCRARY M, LEE P, TYRING SK: Fanwiclovir: a review of clinical efficacy and safety. Antiviral Res. (1996) 29:141–151.
  • ARVIN AM: Varicella-zoster virus. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York (1996):2547–2586.
  • ARVIN AM, MOFFAT JF, REDMAN R: Varicella-zoster virus: aspects of pathogenesis and the host response to natu-ral infection and varicella vaccine. Adv. Viral Res. (1996) 46:265–307
  • COHEN JI, STRAUS SE: Varicella-zoster virus and its replication- In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York. (1996):2525–2546.
  • NIKKELS AF, PIERARD GE: Current therapies for shin-gles. Exp. Opin. Invest. Drugs (1996) 5:185–196.
  • BRITT WJ, ALFORD CA: Cytomegalovirus. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York (1996):2493–2524.
  • MELNICK JL, ADAM E, DEBAKEY ME: Cytomegalovirus and atherosclerosis. BioEssays (1995) 17:899–903.
  • PLACHTER B, SINZGER C, JAHN G: Cell types involved in replication and distribution of human cytomega-lovirus. Adv. Viral. Res. (1996) 46:197–241.
  • FISH KN, BRITT W, NELSON JA: A novel mechanism for persistence of human cytomegalovirus in macro-phages.]. Virol. (1996) 70: 1855-1862.
  • RONDO K, KANESHIMA H, MOCARSKI ES: Human cy-tomegalovirus latent infection of granulocyte-macro-phage progenitors. Proc. Natl. Acad. Sci. USA (1994) 91:11879–11883.
  • STENBERG RM, KERRY JA: Cytomegalovirus genes: their structure and function. Scand. J. Infect. Dis . (1995) S99:3–6.
  • MOCARSKI ES: Cytomegaloviruses and their replication. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York (1996):2447–2492.
  • GRIFFITHS PD: Parameters for the successful manage-ment of cytomegalovirus. Antiviral Chem. Chemother. (1995) 6\(Suppl. 1):7–11.
  • YOUNG LS: Epstein-Barr virus: general features. In: Encyclopedia of Virology. Webster RG, Granoff A (Eds.), Academic Press (1995):404–409.
  • RICKINSON AB, KIEFF E: Epstein-Barr virus. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Raven Press, New York (1996):2397–2446
  • THOMAS JA, ALLDAY MJ, CRAWFORD DH: Epstein-Barr virus-associated lymphoproliferative disorders in fin-munocompromised individuals. Adv. Cancer Res. (1991) 57:329–380.
  • KLEIN G: Viral latency and transformation: the strategy of Epstein-Barr virus. Cell (1989) 58:5–8.
  • KIEFF E: Epstein-Barr virus and its replication. In: Virol-ogy. Fields BN, Knipe DM, Howley PM (Eds.), Lippincott-Ra-ven Press, New York (1996):2343–2396.
  • YAMANISHI K: Human herpesvirus 6. Int. Antiviral News (1996) 4:59–60.
  • LUSSO P: Human herpesvirus 6 (HHV-6). Antiviral Res. (1996) 31:1–21.
  • KRUEGER GRF, KLUEPPELBERG U, HOFFMAN A, ABLASHI DV: Clinical correlates of infection with human herpes-virus-6. In Vivo (1994) 8:457–486.
  • CHALLONER PB, SMITH KT, PARKER JD et al.: Plaque-as-sociated expression of human herpesvirus 6 in multiple sclerosis. Proc. Natl. Acad. Sci. USA (1995) 92:7440–7444.
  • HERNDON RM: Herpesviruses in multiple sclerosis. Arch. Neurol. (1996) 53:123–124.
  • LUSSO P, GALLO RC: Human herpesvirus 6 in AIDS Immunol. Today (1995) 16:67–71.
  • FRENICEL N, ROFFMAN E: Human herpesvirus 7. In: Virology. Fields BN, Knipe DM, Howley PM (Eds.), Lippin-cott-Raven Press, New York (1996):2609–2622.
  • AMBROZIAK JA, BLACKBOURN DJ, HERNDIER BG et aL: Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science (1995) 268:582–583.
  • Herpes viruses. In: Antiviral Chemotherapy. Jeffries DJ, DeClercq E (Eds.), J Wiley 8r Sons (1995):81–284.
  • DUTIA BM: Ribonucleotide reductase induced by herpes simplex virus has a virus specified constituent.]. Gen. Virol. (1993) 64:513–521
  • BRANDT C.R, SPENCER B, IMESCH P, GARNEAU M, DEZLEL R: Evaluation of a peptidomimetic ribonucleotide re-ductase inhibitor with a murine model of herpes sim-plex virus type 1 ocular disease, Antimicrobial Agents Chernother. (1996) 40:1078-1084. and analysis of the human cytomegalovirus UL80-en-
  • BAUM EZ, BEBERNITZ GA, HULMES JD et a/ Expression and analysis of the human cytomegalovirus WO-encoded protease: identification of autoproteolytic sites.
  • FRUH K, AHN K, DJABALLAH H el a1 Aviral inhibitor of peptide transporters for antigen presentation Nature 1 Mwl (1993) 67 497–506 (1995) 375 415–418
  • FRIEDLAND JS Chemoklnes in vlial disease. Res Vzml (1996) 147 131–138
  • MEINI E, FICKENSCHER �1, FLECKENSTEIN B Chemokine receptors and chemoklne-inducing molecuies of lymphotrophic herpesviruses. Immunol Today (1996) 17 199
  • WIERTZ EJHJ, JONES TR, LEI SUN el a1 The human cytomegalovjrus US11 gene produd dislocates MHC c h s 1 heavy chains from the endoplasmic reticulum to the cytosol. Cell (1996) 84 769–779
  • FARREL HE, MCLEAN CS, EFSTATHIOU S, INGLIS S, MIN SON AC Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deletea/
  • LIU F, ROIZMAN B The promoter, transcription unlt and coding sequences of herpes simplex virus 1 family 35 proteins are contained withb and in frame with the u1.26 open reading Erame. J Mml (1991) 65 206–212

References to Patent Literature

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.